Cevostamab Biosimilar (- FcRH5 / IRTA2 / CD307e Reference Antibody)
Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells.
Product Specifications
Target
Cevostamab Biosimilar (Anti- FcRH5 / IRTA2 / CD307e Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470489-100 1x 100 µL
Topoisomerase (DNA) I, Mitochondrial (TOP1MT) (TOP1MT/568), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
